Keywords: محاکمه فاز دوم; Amrubicin; Small-cell lung cancer; Refractory relapse; Phase II trial;
مقالات ISI محاکمه فاز دوم (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Adjuvant postoperative high-dose radiotherapy for atypical and malignant meningioma: A phase-II parallel non-randomized and observation study (EORTC 22042-26042)
Keywords: محاکمه فاز دوم; Atypical meningioma; Malignant meningioma; Phase II trial; Observational study; Radiotherapy; Dose escalation;
A randomized phase II study of LY2510924 and carboplatin/etoposide versus carboplatin/etoposide in extensiveâdisease small cell lung cancer
Keywords: محاکمه فاز دوم; CXCR4; LY2510924; Extensive-disease small cell lung cancer; Phase II trial;
Phase II trial of weekly nab-paclitaxel for previously treated advanced non-small cell lung cancer: Kumamoto thoracic oncology study group (KTOSG) trial 1301
Keywords: محاکمه فاز دوم; Non-small cell lung cancer; Nab-paclitaxel; Objective response rate; Overall survival; Phase II trial;
Biweekly Pegylated Liposomal Doxorubicin (Caelyx) in Heavily Pretreated Metastatic Breast Cancer: A Phase 2 Study
Keywords: محاکمه فاز دوم; Advanced breast cancer; Anthracyclines; Pegylated liposomal doxorubicin (PLD); Phase II Trial;
Is there still a role for sorafenib in metastatic renal cell carcinoma? A systematic review and meta-analysis of the effectiveness of sorafenib over other targeted agents
Keywords: محاکمه فاز دوم; Sorafenib; Sunitinib; Axitinib; Tivozanib; MRCC; Second line; First line; Phase III trial; Phase II trial;
A prospective phase II trial of EGCG in treatment of acute radiation-induced esophagitis for stage III lung cancer
Keywords: محاکمه فاز دوم; Epigallocatechin-3-gallate (EGCG); Acute radiation-induced esophagitis (ARIE); Phase II trial;
A phase II evaluation of the potent, highly selective PARP inhibitor veliparib in the treatment of persistent or recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer in patients who carry a germline BRCA1 or BRCA2 mutation — An NRG O
Keywords: محاکمه فاز دوم; Veliparib; Ovarian cancer; PARP inhibitor; Toxicity; Phase II trial; BRCA1, BRCA2 mutation
A phase II evaluation of selumetinib (AZD6244, ARRY-142886), a selective MEK-1/2 inhibitor in the treatment of recurrent or persistent endometrial cancer: An NRG Oncology/Gynecologic Oncology Group study
Keywords: محاکمه فاز دوم; Selumetinib; endometrial cancer; MEK inhibitor; toxicity; Phase II trial;
A phase II study of cisplatin plus S-1 with concurrent thoracic radiotherapy for locally advanced non-small-cell lung cancer: The Okayama Lung Cancer Study Group Trial 0501
Keywords: محاکمه فاز دوم; Cisplatin; S-1; Radiation; Chemotherapy; Stage III; Phase II trial;
A randomized phase II efficacy and correlative studies of cetuximab with or without sorafenib in recurrent and/or metastatic head and neck squamous cell carcinoma
Keywords: محاکمه فاز دوم; Cetuximab; Sorafenib; Head and neck squamous cell carcinoma; Recurrence; Metastasis; p16; TGFβ1; Response; Toxicity; Phase II trial
A phase II trial of intraperitoneal EGEN-001, an IL-12 plasmid formulated with PEG–PEI–cholesterol lipopolymer in the treatment of persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer: A Gynecologic Oncology Group study
Keywords: محاکمه فاز دوم; Phase II trial; Gene therapy; Ovarian cancer
Lenalidomide Plus Melphalan Without Prednisone for Previously Untreated Older Patients With Multiple Myeloma: A Phase II Trial
Keywords: محاکمه فاز دوم; Corticosteroids; Lenalidomide; Melphalan; Multiple myeloma; Phase II trial;
Phase II study of temsirolimus (CCI-779) in women with recurrent, unresectable, locally advanced or metastatic carcinoma of the cervix. A trial of the NCIC Clinical Trials Group (NCIC CTG IND 199)
Keywords: محاکمه فاز دوم; Cervical cancer systemic therapy; Temsirolimus; Phase II trial; mTOR pathway;
Maintenance sunitinib or observation in metastatic pancreatic adenocarcinoma: A phase II randomised trial
Keywords: محاکمه فاز دوم; Anti-angiogenic therapy; Maintenance therapy; Metastatic disease; Pancreas; Pancreatic adenocarcinoma; Pancreatic cancer; Phase II trial; Randomised trial; Sunitinib;
Optimal continuous-monitoring design of single-arm phase II trial based on the simulated annealing method
Keywords: محاکمه فاز دوم; Simulated annealing; Simon's design; Early stopping; Adaptive design; Bayesian inference; Phase II trial; Type I error; Type II error; Optimal design;
A Phase II Study of the Histone Deacetylase Inhibitor Panobinostat (LBH589) in Pretreated Patients with Small-Cell Lung Cancer
Keywords: محاکمه فاز دوم; Panobinostat; LBH58; Small-cell lung cancer; Phase II trial; Deacetylase inhibitor.
Cost Analysis of Erlotinib Versus Chemotherapy for First-Line Treatment of Non–Small-Cell Lung Cancer in Frail Elderly Patients Participating in a Prospective Phase 2 Study (GFPC 0505)
Keywords: محاکمه فاز دوم; Cost-utility; Elderly patients; Erlotinib; Phase II trial
Carboplatin and Paclitaxel Plus ASA404 as First-Line Chemotherapy for Extensive-Stage Small-Cell Lung Cancer: A Multicenter Single Arm Phase II Trial (SAKK 15/08)
Keywords: محاکمه فاز دوم; Extensive stage small cell lung cancer; Phase II trial; Serotonin; Small cell; Vascular disrupting; Vascular disruptive agent
Phase II trial of adjuvant pelvic radiation “sandwiched” between combination paclitaxel and carboplatin in women with uterine papillary serous carcinomaâ
Keywords: محاکمه فاز دوم; Uterine cancer; UPSC; Radiation therapy; Chemotherapy; Adjuvant treatment; Phase II trial;
Phase II trial of adjuvant pelvic radiation “sandwiched” between ifosfamide or ifosfamide plus cisplatin in women with uterine carcinosarcomaâ
Keywords: محاکمه فاز دوم; Uterine cancer; Carcinosarcoma; Adjuvant therapy; Radiation therapy; Ifosfamide; Phase II trial;
Randomized phase II trial of carboplatin and paclitaxel with or without lonafarnib in first-line treatment of epithelial ovarian cancer stage IIB–IV
Keywords: محاکمه فاز دوم; Ovarian cancer; Phase II trial; Lonafarnib; Farnesytransferase inhibition; Firstline treatment
A multi-institutional phase II trial of paclitaxel and carboplatin in the treatment of advanced or recurrent cervical cancer
Keywords: محاکمه فاز دوم; Carboplatin; Paclitaxel; Cervical cancer; Metastatic; Recurrent; Phase II trial;
Phase II trial of paclitaxel and nedaplatin in patients with advanced/recurrent uterine cervical cancer: A Kansai Clinical Oncology Group study
Keywords: محاکمه فاز دوم; Phase II trial; Advanced or recurrent cervical cancer; Paclitaxel; Nedaplatin
A phase II trial of thalidomide in patients with refractory uterine carcinosarcoma and correlation with biomarkers of angiogenesis: A Gynecologic Oncology Group study
Keywords: محاکمه فاز دوم; Thalidomide; Refractory uterine carcinosarcoma; Angiogenesis biomarkers; GOG; Phase II trial
Predictive value of serum CA-125 levels in patients with persistent or recurrent epithelial ovarian cancer or peritoneal cancer treated with bevacizumab on a Gynecologic Oncology Group phase II trial ★
Keywords: محاکمه فاز دوم; Ovarian cancer; Bevacizumab; CA-125; Phase II trial; Response assessment
A multicenter phase II randomized trial of gemcitabine followed by erlotinib at progression, versus the reverse sequence, in vulnerable elderly patients with advanced non small-cell lung cancer selected with a comprehensive geriatric assessment (the GFPC
Keywords: محاکمه فاز دوم; Frail elderly; Co-morbidities; Phase II trial; Chemotherapy; Lung cancer
Phase II trial of the histone deacetylase inhibitor romidepsin in patients with recurrent/metastatic head and neck cancer
Keywords: محاکمه فاز دوم; Romidepsin; Head and neck cancer; Squamous cell carcinoma; Histone deacetylase (HDAC) inhibitors; Phase II trial
Pre-operative bevacizumab, capecitabine, oxaliplatin and radiation among patients with locally advanced or low rectal cancer: A phase II trial
Keywords: محاکمه فاز دوم; Bevacizumab; Capecitabine; Oxaliplatin; Radiotherapy; Locally advanced rectal cancer; Phase II trial
Phase II trial of paclitaxel and uracil–tegafur in metastatic breast cancer. TEGATAX trial
Keywords: محاکمه فاز دوم; Metastatic breast cancer; Paclitaxel; Tegafur–uracil; Phase II trial
Ifosfamide, paclitaxel, and carboplatin, a novel triplet regimen for advanced, recurrent, or persistent carcinoma of the cervix: A phase II trial
Keywords: محاکمه فاز دوم; Cervical cancer; Carboplatin; Paclitaxel; Ifosfamide; Phase II trial;
Clinical development of dietary supplements: The perils of starting at phase III
Keywords: محاکمه فاز دوم; FDA, Food and Drug Administration.Dietary supplements; Phase II trial; Phase III trial; Efficacy; Placebo effect
Phase II trial of amrubicin and carboplatin in patients with sensitive or refractory relapsed small-cell lung cancer
Keywords: محاکمه فاز دوم; Amrubicin; Carboplatin; Phase II trial; Refractory relapsed; Sensitive relapsed; Small-cell lung cancer;
S-1 Plus Cisplatin with Concurrent Radiotherapy for Locally Advanced Non-small Cell Lung Cancer: A Multi-Institutional Phase II Trial (West Japan Thoracic Oncology Group 3706)
Keywords: محاکمه فاز دوم; Concurrent chemoradiotherapy; Non-small cell lung cancer; Phase II trial; S-1; Cisplatin
Acceptability and adherence: findings from a Phase II study of a candidate vaginal microbicide, 'Praneem polyherbal tablet', in Pune, India
Keywords: محاکمه فاز دوم; Praneem; Vaginal tablet; Acceptability; Medication adherence; Phase II trial; Safe sex;
A multicentre Phase II study of non-pegylated liposomal doxorubicin in combination with trastuzumab and docetaxel as first-line therapy in metastatic breast cancer
Keywords: محاکمه فاز دوم; Non-pegylated liposomal doxorubicin; Docetaxel; Trastuzumab; Phase II trial; Cardiotoxicity; Metastatic breast cancer
A phase II study of amrubicin, a synthetic 9-aminoanthracycline, in patients with previously treated lung cancer
Keywords: محاکمه فاز دوم; Amrubicin; Relapse; Phase II trial; Non-small cell lung cancer; Small cell lung cancer; Previously treated lung cancer;
Multicentric parallel phase II trial of the polo-like kinase 1 inhibitor BI 2536 in patients with advanced head and neck cancer, breast cancer, ovarian cancer, soft tissue sarcoma and melanoma. The first protocol of the European Organization for Research
Keywords: محاکمه فاز دوم; Phase II trial; Polo-like kinase inhibitor; PLK; BI 2536; Small molecule; Head and neck cancer; Breast cancer; Ovarian cancer; Soft tissue sarcoma; Melanoma
The Deliverability, Acceptability, and Perceived Effect of the Macmillan Approach to Weight Loss and Eating Difficulties: A Phase II, Cluster-Randomized, Exploratory Trial of a Psychosocial Intervention for Weight- and Eating-Related Distress in People wi
Keywords: محاکمه فاز دوم; Phase II trial; mixed methods; cancer cachexia; weight loss; anorexia; psychosocial support; weight-related distress; eating-related distress
Mayo Acute Stroke Trial for Enhancing Recovery (MASTER) Protocol
Keywords: محاکمه فاز دوم; Donepezil; ischemic stroke; National Institute of Neurological Disorders and Stroke tissue plasminogen activator trial; recovery; rehabilitation; phase II trial
A novel diagram and complement to the CONSORT chart for presenting multimodal clinical trials
Keywords: محاکمه فاز دوم; Consort chart; Clinical trial results; Patient flow chart; Phase II trial
Safety and pharmacokinetics of plasma-derived mannose-binding lectin (MBL) substitution in children with chemotherapy-induced neutropaenia
Keywords: محاکمه فاز دوم; Mannose-binding lectin; Phase II trial; Chemotherapy; Pharmacokinetics
Bi-weekly administration of gemcitabine plus vinorelbine in elderly patients with advanced non-small-cell lung cancer: Multicenter phase II trial
Keywords: محاکمه فاز دوم; Elderly patients; Non-small-cell lung caner; Bi-weekly schedule; Gemcitabine; Vinorelbine; Phase II trial
An open multicenter phase II trial of weekly docetaxel for advanced-stage non-small-cell lung cancer in elderly patients with significant comorbidity and/or poor performance status: The GFPC 02-02b study
Keywords: محاکمه فاز دوم; Elderly; Comorbidity; Phase II trial; Chemotherapy; Lung cancer
Brostallicin, an agent with potential activity in metastatic soft tissue sarcoma: A phase II study from the European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group
Keywords: محاکمه فاز دوم; Soft tissue sarcoma; Gastrointestinal stromal tumour; GIST; Brostallicin; Phase II trial; Minor groove binder; Progression free survival;
An open multicenter phase II trial of docetaxel–gemcitabine in Charlson score and performance status (PS) selected elderly patients with stage IIIB pleura/IV non-small-cell lung cancer (NSCLC): The GFPC 02-02a study
Keywords: محاکمه فاز دوم; Chemotherapy; Comorbidity; Elderly; Lung cancer; Phase II trial
Induction chemotherapy with the TIP regimen (paclitaxel/ifosfamide/cisplatin) in stage III non-small cell lung cancer
Keywords: محاکمه فاز دوم; Induction chemotherapy; Non-small cell lung cancer stage III; Phase II trial; Paclitaxel; Ifosfamide; Cisplatin;
Phase II study of capecitabine single-agent therapy in patients with metastatic renal cell carcinoma
Keywords: محاکمه فاز دوم; Renal cell carcinoma; Capecitabine; Phase II trial
Phase II Trial of Paclitaxel, Carboplatin, and Topotecan with G-CSF Support in Previously Untreated Patients with Extensive Stage Small Cell Lung Cancer: Southwest Oncology Group 9914
Keywords: محاکمه فاز دوم; Small cell lung cancer; chemotherapy; phase II trial;
Phase II Study of Carboplatin Combined with Biweekly Docetaxel for Advanced Non-small Cell Lung Cancer
Keywords: محاکمه فاز دوم; Chemotherapy; Docetaxel; Biweekly; Carboplatin; Phase II trial; Non-small cell lung cancer